Jane Street Group, LLC Agios Pharmaceuticals, Inc. Call Options Transaction History

Jane Street Group, LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$41.19 - $49.72 $341,877 - $412,676	8,300 New	8,300 $368,000
Q1 2022 May 17, 2022	SELL	$26.68 - $34.81 $2.59 Million - $3.37 Million	-96,900 Reduced 80.28%	23,800 $693,000
Q4 2021 Feb 15, 2022	BUY	$29.58 - $49.78 $331,296 - $557,536	11,200 Added 10.23%	120,700 $3.97 Million
Q3 2021 Nov 16, 2021	BUY	$41.92 - $58.18 $570,112 - $791,248	13,600 Added 14.18%	109,500 $5.05 Million
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $1.29 Million - $1.51 Million	24,700 Added 34.69%	95,900 $5.29 Million
Q1 2021 May 18, 2021	SELL	$44.23 - $57.5 $1.61 Million - $2.09 Million	-36,300 Reduced 33.77%	71,200 $3.68 Million
Q4 2020 Feb 17, 2021	BUY	$33.21 - $46.54 $1.33 Million - $1.87 Million	40,100 Added 59.5%	107,500 $4.66 Million
Q3 2020 Nov 17, 2020	SELL	$33.87 - $55.93 $2.23 Million - $3.69 Million	-65,900 Reduced 49.44%	67,400 $2.36 Million
Q2 2020 Aug 17, 2020	BUY	$34.45 - $53.48 $4.28 Million - $6.64 Million	124,100 Added 1348.91%	133,300 $7.13 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $501,168 - $855,579	-15,900 Reduced 63.35%	9,200 $326,000
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $755,008 - $1.27 Million	25,100 New	25,100 $1.2 Million
Q4 2018 Feb 15, 2019	SELL	$42.73 - $76.53 $153,828 - $275,508	-3,600 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $229,344 - $294,240	-3,200 Reduced 47.06%	3,600 $278,000
Q2 2018 Aug 15, 2018	BUY	$73.22 - $99.55 $497,896 - $676,940	6,800 New	6,800 $573,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.